Dr Bal discusses new research suggesting that fine motor skills could be predictive of long-term language disabilities among individuals with autism spectrum disorder. For more, visit www.consultant360.com

In this podcast, Jordan Grumet, MD, talks about his session at this year's Cardiometabolic Risk Summit about how sharing your story with patients via social media and other avenues can help bridge the intimacy gap. More at: www.consultant360.com/cardiology.

In this podcast, Mark Hallett, MD, talks about his upcoming session at the American Neurological Association's Annual Meeting about functional neurologic disorders, how to deliver the diagnosis to patients, and how to better integrate care. More at: www.consultant360.com/neurology.

In this podcast, David Alland, PhD, answers our questions about his research on drug-resistant tuberculosis, which may pave the way for future treatments for the disease. More at: www.consultant360.com/infectious-diseases.

Robert S. Laitman, MD, discusses evidence supporting the reclassification of schizophrenia as a neurological disorder, his views on how reclassification could impact prognosis and recovery, and treatment interventions he says have led to meaningful recovery in his patients with schizophrenia. For more, visit www.consultant360.com.

Angela Fitch, MD, from Massachusetts General Hospital, discusses evidence-based management of obesity in primary care, including nutrition and physical activity interventions, and the pillars of treatment. For more, visit www.consultant360.com.

In this podcast, Harold Bays, MD, gives an overview of his session at our upcoming Cardiometabolic Risk Summit, which includes a discussion about non-alcoholic fatty liver disease, how fat affects the liver, and why patients (and cardiologists) should worry about this disease. More at: www.consultant360.com/cardiology.

In this podcast, Donna Ryan, MD, MABOM, talks about evaluating obesity medications, her tips for choosing the right medication for the right patient, and medications that are on the horizon. This is also the topic of her session at our Cardiometabolic Risk Summit 2019 in October. More at: www.consultant360.com/cardiology.

Stephen Harrison, MD, from Pinnacle Clinical Research, discusses the prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the United States, the correlation between NAFLD and obesity, and more.

More at: www.consultant360.com/gastroenterology.

In this podcast, David G. Hill, MD, talks about the top questions about idiopathic pulmonary fibrosis (IPF) that he receives from his colleagues in primary care, how to answer them, and everything else you need to know about IPF. More at: www.consultant360.com/pulmonology.